News Roche adds to pipeline with Poseida, Kiniksa deals Roche has announced a pair of licensing deals with Poseida Therapeutics and Kiniksa Pharmaceuticals that bolster its pipeline in cancer and inflammatory diseases.
Partner Content Partner Content New speaker session with Kiniksa Pharmaceuticals at Pre-fill... Session with Kiniksa Pharmaceuticals at PFS East Coast
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.